UnitedHealth Group Incorporated $UNH Shares Purchased by IMZ Advisory Inc

IMZ Advisory Inc increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 92.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,116 shares of the healthcare conglomerate’s stock after purchasing an additional 536 shares during the quarter. UnitedHealth Group accounts for 0.1% of IMZ Advisory Inc’s investment portfolio, making the stock its 28th biggest holding. IMZ Advisory Inc’s holdings in UnitedHealth Group were worth $348,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. H&H Retirement Design & Management INC raised its holdings in UnitedHealth Group by 10.6% during the second quarter. H&H Retirement Design & Management INC now owns 774 shares of the healthcare conglomerate’s stock worth $241,000 after purchasing an additional 74 shares during the last quarter. Castle Rock Wealth Management LLC increased its position in UnitedHealth Group by 63.2% during the second quarter. Castle Rock Wealth Management LLC now owns 1,072 shares of the healthcare conglomerate’s stock worth $334,000 after buying an additional 415 shares in the last quarter. Morton Capital Management LLC CA increased its position in UnitedHealth Group by 69.2% during the second quarter. Morton Capital Management LLC CA now owns 660 shares of the healthcare conglomerate’s stock worth $206,000 after buying an additional 270 shares in the last quarter. Navera Investment Management Ltd. increased its position in UnitedHealth Group by 13.1% during the second quarter. Navera Investment Management Ltd. now owns 644,636 shares of the healthcare conglomerate’s stock worth $201,042,000 after buying an additional 74,702 shares in the last quarter. Finally, Lansing Street Advisors increased its position in UnitedHealth Group by 6.8% during the second quarter. Lansing Street Advisors now owns 771 shares of the healthcare conglomerate’s stock worth $241,000 after buying an additional 49 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on UNH. KeyCorp raised their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday. Robert W. Baird reissued an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Wells Fargo & Company lifted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $372.68.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $369.88 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market capitalization of $334.99 billion, a P/E ratio of 16.03, a PEG ratio of 2.35 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s fifty day moving average price is $313.51 and its 200 day moving average price is $352.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.